Cognitive Stimulation in Patients With Sclerosis Multiple
JUGUEMOS - Cognitive Stimulation Through Games : a New Active Aging Approach to Enhance Users' Everyday Challenges Sclerosis Multiple
What it found
We found no results in the registry or in papers.
This trial finished 10 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- cognitive stimulation through games
What it measured
Main measures
Capacity to stimulate the functions cognitive, is why cognitive stimulation through strategies and neuropsychological specific set of board games, improve cognitive performance in patients with RRMS and PMSC .
Cognitive performance baseline (pre intervention) at 6 months (post intervention)
Thinking and memoryMood and sleepQuality of life (reported by participants)
Other measures (2)
Positive social interaction generated by the group reinforcement groups treatment will lead to improved mood of its participants.
Social interaction, baseline (pre intervention) at 6 months (post intervention)
Mood and sleepCognitive improvement achieved after participation in a group of cognitive stimulation through strategies and neuropsychological games, improve the quality of life Patients with RRMS and SPMS .
Quality of life (baseline, pre intervention) at 6 months (post intervention)
Thinking and memoryFatiguePainQuality of life (reported by participants)
Who could take part
Relapsing and progressive · 18 to 65
Show the full criteria
Inclusion criteria
* Clinical diagnosis of RRMS or SPMS according to Poser criteria (1983) and McDonald (2001). * Degree of disability between 1 ( clinical signs without disability) and 5.5 (capable of walk 100 meters without aid or rest , disability severe enough to prevent the activities of the whole ) day as the Disability Scale Kurtze (EDSS , 1983). * Basic treatment for first-line MS ( immunomodulators). * Complaints cognitive, functional gradation in the scale of dementia GDS ( Global Dementia Staging ) of Reisberg (1982 ) 2 and 4 . * Patients who have mild to moderate cognitive impairment (have between 20 and 40 % of the altered neuropsychological tests). * Signed informed consent .
Exclusion criteria
* Cognitive impairment associated with other medical diseases (Alzheimer's, stroke, Parkinson's disease, kidney disease, respiratory, hepatic, endocrine or hematological). * Diagnosis of primary psychiatric disease with cognitive impairment in accordance with DSM-IV-TR criteria: schizophrenia, bipolar disorder, personality… * Diagnosis or history of substance abuse or dependence. * Score the Beck Depression Inventory II (BDI-II) greater than or equal to 30. * Low Intelectual coeficient, inferred through obtaining a scale score less than 4 on the Vocabulary subtest of the WAIS-IV. * Evidence of delusions, confusion or other disturbances of consciousness. * Severe sensory deficits (visual and / or auditory)or functional illiteracy in which neuropsychological study can not be carried out. * Patients treated with immunosuppressive drugs base or second line. * Patients who are already receiving treatment or have cognitive rehabilitation received in the last 12 months.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The primary objective of the study is to determine if the training for 6 months with a specific set of games ( previously selected according to the cognitive domain stimulate : attention, memory , executive functions and processing speed ) , so improve significant neuropsychological performance of patients with Multiple Sclerosis Sender Recurrent ( RRMS ) and secondary progressive multiple sclerosis (SPMS ) , your mood and your quality of life. Design : randomized clinical trial with a control group , coordinated a multicenter sample preselected patients.
Loading reviews and guidelines…
History
Started
Feb 2016
Main results due
Sept 2016
Finished
May 2017